)
)
Dicot Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Dicot
Access all reports
Dicot AB is a pharmaceutical company focused on the development of lifestyle drugs, primarily addressing sexual health issues such as erectile dysfunction and premature ejaculation. Founded in 2021, Dicot conducts drug discovery and development aimed at improving quality of life for patients with these conditions. The company's main research involves the drug candidate LIB-01, which is in the early stages of clinical trials. Dicot AB is a private entity and maintains active operations, contributing to the healthcare and drug development sectors. The company is headquartered in Uppsala, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Ticker symbol
DICOT
Country
🇸🇪 Sweden